Structure

Physi-Chem Properties

Molecular Weight:  365.02
Volume:  306.081
LogP:  3.199
LogD:  2.816
LogS:  -4.338
# Rotatable Bonds:  4
TPSA:  60.94
# H-Bond Aceptor:  4
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.657
Synthetic Accessibility Score:  3.541
Fsp3:  0.267
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.957
MDCK Permeability:  1.141648226621328e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.854
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.004

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.541
Plasma Protein Binding (PPB):  73.18658447265625%
Volume Distribution (VD):  2.017
Pgp-substrate:  27.89931869506836%

ADMET: Metabolism

CYP1A2-inhibitor:  0.963
CYP1A2-substrate:  0.899
CYP2C19-inhibitor:  0.715
CYP2C19-substrate:  0.119
CYP2C9-inhibitor:  0.342
CYP2C9-substrate:  0.785
CYP2D6-inhibitor:  0.624
CYP2D6-substrate:  0.906
CYP3A4-inhibitor:  0.472
CYP3A4-substrate:  0.753

ADMET: Excretion

Clearance (CL):  5.223
Half-life (T1/2):  0.381

ADMET: Toxicity

hERG Blockers:  0.605
Human Hepatotoxicity (H-HT):  0.825
Drug-inuced Liver Injury (DILI):  0.863
AMES Toxicity:  0.454
Rat Oral Acute Toxicity:  0.975
Maximum Recommended Daily Dose:  0.947
Skin Sensitization:  0.393
Carcinogencity:  0.487
Eye Corrosion:  0.003
Eye Irritation:  0.016
Respiratory Toxicity:  0.977

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC245348

Natural Product ID:  NPC245348
Common Name*:   Eudistomidin C
IUPAC Name:   5-bromo-1-[(1S)-1-(methylamino)-2-methylsulfanylethyl]-9H-pyrido[3,4-b]indol-6-ol
Synonyms:   Eudistomidin C
Standard InCHIKey:  RGJZFVKMTLBCJY-SNVBAGLBSA-N
Standard InCHI:  InChI=1S/C15H16BrN3OS/c1-17-10(7-21-2)15-14-8(5-6-18-15)12-9(19-14)3-4-11(20)13(12)16/h3-6,10,17,19-20H,7H2,1-2H3/t10-/m1/s1
SMILES:  CSC[C@H](c1nccc2c1[nH]c1c2c(Br)c(cc1)O)NC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1800684
PubChem CID:   23426231
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000279] Alkaloids and derivatives
      • [CHEMONTID:0001140] Harmala alkaloids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4412 Vepris stolzii Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO7903 Ascochyta fabae Species Didymellaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO3258 Parmelia glabra Species Parmeliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO8196 Leucanthemum aligulatum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO2552 Shorea acuminata Species Dipterocarpaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT137 Cell Line L1210 Mus musculus IC50 = 0.36 ug.mL-1 PMID[487575]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC245348 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9851 High Similarity NPC60006
0.8986 High Similarity NPC255110
0.8955 High Similarity NPC476124
0.8768 High Similarity NPC476121
0.8539 High Similarity NPC97902
0.8537 High Similarity NPC475070
0.8476 Intermediate Similarity NPC477610
0.8416 Intermediate Similarity NPC222018
0.8148 Intermediate Similarity NPC477609
0.8109 Intermediate Similarity NPC171171
0.81 Intermediate Similarity NPC204717
0.8075 Intermediate Similarity NPC5145
0.806 Intermediate Similarity NPC314002
0.805 Intermediate Similarity NPC220765
0.8029 Intermediate Similarity NPC476167
0.8028 Intermediate Similarity NPC292958
0.8018 Intermediate Similarity NPC476041
0.8018 Intermediate Similarity NPC304926
0.8 Intermediate Similarity NPC99666
0.799 Intermediate Similarity NPC176538
0.7982 Intermediate Similarity NPC477607
0.7982 Intermediate Similarity NPC477608
0.7981 Intermediate Similarity NPC192315
0.7913 Intermediate Similarity NPC39092
0.7913 Intermediate Similarity NPC324149
0.787 Intermediate Similarity NPC246518
0.785 Intermediate Similarity NPC184964
0.7847 Intermediate Similarity NPC77555
0.7838 Intermediate Similarity NPC470501
0.7793 Intermediate Similarity NPC470502
0.7752 Intermediate Similarity NPC128084
0.7723 Intermediate Similarity NPC470503
0.7699 Intermediate Similarity NPC6215
0.7678 Intermediate Similarity NPC156704
0.7664 Intermediate Similarity NPC211813
0.7647 Intermediate Similarity NPC142901
0.7633 Intermediate Similarity NPC46580
0.7619 Intermediate Similarity NPC307963
0.7593 Intermediate Similarity NPC470505
0.7581 Intermediate Similarity NPC473761
0.757 Intermediate Similarity NPC315491
0.757 Intermediate Similarity NPC45459
0.757 Intermediate Similarity NPC249040
0.757 Intermediate Similarity NPC205254
0.757 Intermediate Similarity NPC23420
0.757 Intermediate Similarity NPC106771
0.757 Intermediate Similarity NPC303820
0.756 Intermediate Similarity NPC76748
0.7547 Intermediate Similarity NPC251090
0.7546 Intermediate Similarity NPC223427
0.7542 Intermediate Similarity NPC470504
0.7535 Intermediate Similarity NPC232727
0.7535 Intermediate Similarity NPC475935
0.7535 Intermediate Similarity NPC94211
0.7535 Intermediate Similarity NPC52909
0.7534 Intermediate Similarity NPC80596
0.7534 Intermediate Similarity NPC476116
0.7524 Intermediate Similarity NPC92111
0.7512 Intermediate Similarity NPC470500
0.7512 Intermediate Similarity NPC296527
0.7512 Intermediate Similarity NPC32771
0.7489 Intermediate Similarity NPC200553
0.7488 Intermediate Similarity NPC213308
0.7468 Intermediate Similarity NPC295228
0.7467 Intermediate Similarity NPC213530
0.7467 Intermediate Similarity NPC193267
0.7465 Intermediate Similarity NPC245816
0.7465 Intermediate Similarity NPC476138
0.7465 Intermediate Similarity NPC476098
0.7463 Intermediate Similarity NPC88363
0.7451 Intermediate Similarity NPC474958
0.744 Intermediate Similarity NPC48938
0.7418 Intermediate Similarity NPC326634
0.7414 Intermediate Similarity NPC207686
0.7411 Intermediate Similarity NPC470799
0.7411 Intermediate Similarity NPC8022
0.7404 Intermediate Similarity NPC41679
0.7399 Intermediate Similarity NPC266931
0.7393 Intermediate Similarity NPC162002
0.7389 Intermediate Similarity NPC82331
0.7384 Intermediate Similarity NPC171393
0.7384 Intermediate Similarity NPC295452
0.7383 Intermediate Similarity NPC242209
0.7373 Intermediate Similarity NPC37152
0.7371 Intermediate Similarity NPC476451
0.735 Intermediate Similarity NPC174489
0.7342 Intermediate Similarity NPC81175
0.7339 Intermediate Similarity NPC279189
0.7336 Intermediate Similarity NPC167908
0.733 Intermediate Similarity NPC96890
0.7327 Intermediate Similarity NPC315957
0.7327 Intermediate Similarity NPC19872
0.7325 Intermediate Similarity NPC310118
0.7309 Intermediate Similarity NPC208284
0.7288 Intermediate Similarity NPC26641
0.7285 Intermediate Similarity NPC88008
0.7277 Intermediate Similarity NPC316981
0.7277 Intermediate Similarity NPC274229
0.7265 Intermediate Similarity NPC167860
0.7265 Intermediate Similarity NPC123976
0.7264 Intermediate Similarity NPC128751
0.7264 Intermediate Similarity NPC246700
0.7261 Intermediate Similarity NPC130570
0.7249 Intermediate Similarity NPC60621
0.7248 Intermediate Similarity NPC121772
0.7246 Intermediate Similarity NPC477549
0.7246 Intermediate Similarity NPC248454
0.723 Intermediate Similarity NPC469497
0.723 Intermediate Similarity NPC106833
0.7227 Intermediate Similarity NPC200836
0.7227 Intermediate Similarity NPC53144
0.722 Intermediate Similarity NPC185782
0.7214 Intermediate Similarity NPC131718
0.7212 Intermediate Similarity NPC72980
0.7209 Intermediate Similarity NPC106937
0.7207 Intermediate Similarity NPC270918
0.72 Intermediate Similarity NPC26679
0.7186 Intermediate Similarity NPC211416
0.7175 Intermediate Similarity NPC477111
0.7175 Intermediate Similarity NPC82548
0.7168 Intermediate Similarity NPC476287
0.7167 Intermediate Similarity NPC110151
0.7163 Intermediate Similarity NPC477166
0.7163 Intermediate Similarity NPC473342
0.7163 Intermediate Similarity NPC304187
0.7163 Intermediate Similarity NPC477167
0.7162 Intermediate Similarity NPC477113
0.7156 Intermediate Similarity NPC284678
0.7155 Intermediate Similarity NPC477861
0.7149 Intermediate Similarity NPC178858
0.7137 Intermediate Similarity NPC216369
0.713 Intermediate Similarity NPC329541
0.713 Intermediate Similarity NPC276657
0.7124 Intermediate Similarity NPC207020
0.7124 Intermediate Similarity NPC219087
0.7123 Intermediate Similarity NPC15102
0.7119 Intermediate Similarity NPC471891
0.7117 Intermediate Similarity NPC285558
0.7109 Intermediate Similarity NPC163055
0.7109 Intermediate Similarity NPC176127
0.7101 Intermediate Similarity NPC474409
0.7098 Intermediate Similarity NPC171787
0.7097 Intermediate Similarity NPC276517
0.7095 Intermediate Similarity NPC473312
0.7091 Intermediate Similarity NPC329793
0.7078 Intermediate Similarity NPC265576
0.7074 Intermediate Similarity NPC27041
0.7071 Intermediate Similarity NPC184225
0.7069 Intermediate Similarity NPC280272
0.7062 Intermediate Similarity NPC307191
0.7062 Intermediate Similarity NPC314394
0.7059 Intermediate Similarity NPC102423
0.7035 Intermediate Similarity NPC85273
0.7032 Intermediate Similarity NPC153042
0.7031 Intermediate Similarity NPC477110
0.7031 Intermediate Similarity NPC469928
0.7031 Intermediate Similarity NPC74969
0.7028 Intermediate Similarity NPC475746
0.7022 Intermediate Similarity NPC476465
0.7019 Intermediate Similarity NPC313791
0.701 Intermediate Similarity NPC282231
0.7009 Intermediate Similarity NPC62749
0.7005 Intermediate Similarity NPC97343
0.7004 Intermediate Similarity NPC153400
0.7 Intermediate Similarity NPC469727
0.6995 Remote Similarity NPC230869
0.6992 Remote Similarity NPC253580
0.6992 Remote Similarity NPC156003
0.6992 Remote Similarity NPC314954
0.699 Remote Similarity NPC49954
0.699 Remote Similarity NPC474561
0.6987 Remote Similarity NPC245055
0.6987 Remote Similarity NPC33064
0.6986 Remote Similarity NPC13880
0.6979 Remote Similarity NPC319232
0.6979 Remote Similarity NPC214142
0.6979 Remote Similarity NPC24370
0.6978 Remote Similarity NPC166492
0.6978 Remote Similarity NPC473362
0.6975 Remote Similarity NPC469554
0.6974 Remote Similarity NPC471603
0.697 Remote Similarity NPC264285
0.6963 Remote Similarity NPC94943
0.6961 Remote Similarity NPC279918
0.696 Remote Similarity NPC11464
0.6957 Remote Similarity NPC63751
0.6957 Remote Similarity NPC183407
0.6949 Remote Similarity NPC304307
0.6949 Remote Similarity NPC118559
0.6949 Remote Similarity NPC261251
0.6949 Remote Similarity NPC34580
0.6949 Remote Similarity NPC124920
0.6949 Remote Similarity NPC470126
0.6948 Remote Similarity NPC212535
0.694 Remote Similarity NPC74360
0.6933 Remote Similarity NPC474145
0.6933 Remote Similarity NPC475841
0.6929 Remote Similarity NPC15801
0.6926 Remote Similarity NPC477114
0.6923 Remote Similarity NPC473764

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC245348 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7961 Intermediate Similarity NPD5575 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD1038 Approved
0.757 Intermediate Similarity NPD484 Approved
0.7536 Intermediate Similarity NPD1304 Clinical (unspecified phase)
0.7512 Intermediate Similarity NPD7948 Phase 1
0.7411 Intermediate Similarity NPD6803 Clinical (unspecified phase)
0.7402 Intermediate Similarity NPD5065 Approved
0.7333 Intermediate Similarity NPD5612 Discontinued
0.7327 Intermediate Similarity NPD1739 Approved
0.7327 Intermediate Similarity NPD1740 Approved
0.7273 Intermediate Similarity NPD4795 Phase 2
0.7264 Intermediate Similarity NPD8110 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD7112 Discontinued
0.7209 Intermediate Similarity NPD802 Phase 2
0.7204 Intermediate Similarity NPD6344 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD2125 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD7603 Discontinued
0.7123 Intermediate Similarity NPD4118 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD8405 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD5040 Clinical (unspecified phase)
0.7022 Intermediate Similarity NPD2189 Approved
0.7022 Intermediate Similarity NPD2187 Approved
0.7018 Intermediate Similarity NPD3324 Clinical (unspecified phase)
0.7005 Intermediate Similarity NPD1326 Approved
0.7005 Intermediate Similarity NPD1325 Approved
0.699 Remote Similarity NPD425 Approved
0.699 Remote Similarity NPD424 Approved
0.6982 Remote Similarity NPD4511 Phase 1
0.6968 Remote Similarity NPD3825 Phase 3
0.6963 Remote Similarity NPD6610 Clinical (unspecified phase)
0.6947 Remote Similarity NPD5658 Approved
0.6943 Remote Similarity NPD1322 Clinical (unspecified phase)
0.6936 Remote Similarity NPD1258 Discontinued
0.6926 Remote Similarity NPD7823 Clinical (unspecified phase)
0.692 Remote Similarity NPD4044 Discontinued
0.692 Remote Similarity NPD4886 Phase 2
0.69 Remote Similarity NPD3330 Phase 1
0.6897 Remote Similarity NPD2021 Discontinued
0.6892 Remote Similarity NPD3814 Phase 1
0.6875 Remote Similarity NPD8073 Approved
0.6875 Remote Similarity NPD3931 Approved
0.6875 Remote Similarity NPD2472 Approved
0.6875 Remote Similarity NPD3928 Approved
0.6875 Remote Similarity NPD2471 Approved
0.6854 Remote Similarity NPD6595 Phase 3
0.6853 Remote Similarity NPD5409 Clinical (unspecified phase)
0.6849 Remote Similarity NPD5559 Phase 2
0.6842 Remote Similarity NPD4184 Clinical (unspecified phase)
0.6838 Remote Similarity NPD6242 Discontinued
0.6829 Remote Similarity NPD5483 Clinical (unspecified phase)
0.6828 Remote Similarity NPD3930 Clinical (unspecified phase)
0.6828 Remote Similarity NPD1392 Approved
0.6828 Remote Similarity NPD6838 Clinical (unspecified phase)
0.6816 Remote Similarity NPD2177 Approved
0.6816 Remote Similarity NPD2175 Phase 3
0.6816 Remote Similarity NPD2176 Approved
0.6784 Remote Similarity NPD3932 Clinical (unspecified phase)
0.6779 Remote Similarity NPD925 Approved
0.6779 Remote Similarity NPD926 Approved
0.6774 Remote Similarity NPD706 Phase 1
0.6773 Remote Similarity NPD3404 Approved
0.677 Remote Similarity NPD8072 Approved
0.6759 Remote Similarity NPD5050 Approved
0.6757 Remote Similarity NPD3127 Clinical (unspecified phase)
0.6754 Remote Similarity NPD7222 Phase 2
0.675 Remote Similarity NPD8512 Phase 3
0.6748 Remote Similarity NPD604 Clinical (unspecified phase)
0.6745 Remote Similarity NPD6492 Phase 2
0.6745 Remote Similarity NPD9690 Approved
0.6742 Remote Similarity NPD9695 Approved
0.6741 Remote Similarity NPD8396 Approved
0.6741 Remote Similarity NPD8395 Approved
0.674 Remote Similarity NPD31 Approved
0.674 Remote Similarity NPD4038 Approved
0.674 Remote Similarity NPD4036 Approved
0.674 Remote Similarity NPD4033 Approved
0.674 Remote Similarity NPD4034 Approved
0.674 Remote Similarity NPD4037 Approved
0.674 Remote Similarity NPD8272 Phase 2
0.674 Remote Similarity NPD4122 Approved
0.674 Remote Similarity NPD32 Approved
0.674 Remote Similarity NPD4039 Approved
0.674 Remote Similarity NPD4035 Approved
0.6736 Remote Similarity NPD7558 Phase 2
0.6732 Remote Similarity NPD8284 Discontinued
0.6723 Remote Similarity NPD4890 Phase 2
0.6715 Remote Similarity NPD9705 Discontinued
0.6715 Remote Similarity NPD112 Approved
0.671 Remote Similarity NPD949 Phase 1
0.6683 Remote Similarity NPD1661 Suspended
0.6681 Remote Similarity NPD4865 Approved
0.6681 Remote Similarity NPD3354 Phase 2
0.6667 Remote Similarity NPD2383 Phase 1
0.6667 Remote Similarity NPD2921 Clinical (unspecified phase)
0.6651 Remote Similarity NPD3609 Approved
0.6651 Remote Similarity NPD2762 Phase 2
0.6651 Remote Similarity NPD3610 Approved
0.6651 Remote Similarity NPD5934 Clinical (unspecified phase)
0.664 Remote Similarity NPD6276 Discontinued
0.6638 Remote Similarity NPD5067 Phase 2
0.6638 Remote Similarity NPD5530 Phase 1
0.6638 Remote Similarity NPD5936 Approved
0.6638 Remote Similarity NPD5066 Phase 2
0.6638 Remote Similarity NPD3003 Approved
0.6638 Remote Similarity NPD5939 Approved
0.6637 Remote Similarity NPD6389 Clinical (unspecified phase)
0.6637 Remote Similarity NPD3395 Approved
0.6637 Remote Similarity NPD3396 Approved
0.6636 Remote Similarity NPD5522 Clinical (unspecified phase)
0.6623 Remote Similarity NPD6991 Approved
0.6614 Remote Similarity NPD8442 Discontinued
0.6614 Remote Similarity NPD4558 Phase 2
0.6609 Remote Similarity NPD7452 Approved
0.6609 Remote Similarity NPD7453 Approved
0.6605 Remote Similarity NPD6159 Phase 2
0.6605 Remote Similarity NPD6203 Clinical (unspecified phase)
0.6598 Remote Similarity NPD4845 Discontinued
0.6598 Remote Similarity NPD4850 Phase 1
0.6595 Remote Similarity NPD3014 Clinical (unspecified phase)
0.6595 Remote Similarity NPD3013 Phase 3
0.6594 Remote Similarity NPD5901 Discontinued
0.6591 Remote Similarity NPD8431 Approved
0.6591 Remote Similarity NPD5590 Clinical (unspecified phase)
0.6589 Remote Similarity NPD482 Approved
0.6587 Remote Similarity NPD704 Clinical (unspecified phase)
0.6581 Remote Similarity NPD2615 Phase 3
0.6581 Remote Similarity NPD8488 Clinical (unspecified phase)
0.6581 Remote Similarity NPD2616 Phase 3
0.6578 Remote Similarity NPD1218 Approved
0.6578 Remote Similarity NPD1219 Approved
0.6577 Remote Similarity NPD459 Clinical (unspecified phase)
0.656 Remote Similarity NPD2094 Phase 2
0.656 Remote Similarity NPD5728 Clinical (unspecified phase)
0.656 Remote Similarity NPD2092 Phase 2
0.656 Remote Similarity NPD2095 Phase 2
0.6558 Remote Similarity NPD749 Clinical (unspecified phase)
0.6558 Remote Similarity NPD5100 Phase 3
0.6556 Remote Similarity NPD7711 Discontinued
0.6552 Remote Similarity NPD6545 Clinical (unspecified phase)
0.6545 Remote Similarity NPD1259 Discontinued
0.6543 Remote Similarity NPD1900 Clinical (unspecified phase)
0.6538 Remote Similarity NPD8458 Clinical (unspecified phase)
0.6537 Remote Similarity NPD1197 Approved
0.653 Remote Similarity NPD2096 Phase 2
0.653 Remote Similarity NPD2091 Phase 2
0.6527 Remote Similarity NPD3254 Phase 1
0.6527 Remote Similarity NPD3255 Phase 1
0.6524 Remote Similarity NPD1685 Approved
0.6524 Remote Similarity NPD1684 Approved
0.6522 Remote Similarity NPD8101 Phase 3
0.6522 Remote Similarity NPD5426 Phase 3
0.652 Remote Similarity NPD7068 Approved
0.652 Remote Similarity NPD7067 Approved
0.652 Remote Similarity NPD1768 Approved
0.6517 Remote Similarity NPD1722 Approved
0.6516 Remote Similarity NPD2062 Phase 2
0.6516 Remote Similarity NPD8106 Phase 2
0.6514 Remote Similarity NPD4203 Approved
0.6514 Remote Similarity NPD4204 Approved
0.6509 Remote Similarity NPD2916 Discontinued
0.6509 Remote Similarity NPD7672 Approved
0.6509 Remote Similarity NPD7671 Approved
0.6507 Remote Similarity NPD5255 Approved
0.6507 Remote Similarity NPD6975 Discontinued
0.6505 Remote Similarity NPD6158 Phase 2
0.6505 Remote Similarity NPD6476 Clinical (unspecified phase)
0.65 Remote Similarity NPD786 Approved
0.6496 Remote Similarity NPD4502 Phase 2
0.6494 Remote Similarity NPD4862 Clinical (unspecified phase)
0.6494 Remote Similarity NPD3962 Phase 2
0.6494 Remote Similarity NPD3959 Phase 2
0.6493 Remote Similarity NPD5140 Approved
0.6493 Remote Similarity NPD5138 Approved
0.6489 Remote Similarity NPD4418 Discontinued
0.6485 Remote Similarity NPD5930 Phase 3
0.6479 Remote Similarity NPD2640 Approved
0.6479 Remote Similarity NPD5069 Clinical (unspecified phase)
0.6479 Remote Similarity NPD2641 Approved
0.6479 Remote Similarity NPD2781 Approved
0.6473 Remote Similarity NPD3924 Approved
0.6473 Remote Similarity NPD3923 Approved
0.6473 Remote Similarity NPD994 Phase 2
0.6473 Remote Similarity NPD3921 Approved
0.6473 Remote Similarity NPD996 Phase 2
0.6473 Remote Similarity NPD3922 Approved
0.6466 Remote Similarity NPD6290 Phase 2
0.6463 Remote Similarity NPD6494 Phase 2
0.6462 Remote Similarity NPD2782 Approved
0.6462 Remote Similarity NPD2780 Approved
0.6457 Remote Similarity NPD5482 Discontinued
0.6446 Remote Similarity NPD4403 Phase 3
0.6446 Remote Similarity NPD4401 Phase 2
0.6444 Remote Similarity NPD3402 Phase 1
0.6444 Remote Similarity NPD534 Phase 2
0.6444 Remote Similarity NPD537 Phase 2
0.6441 Remote Similarity NPD6141 Clinical (unspecified phase)
0.6439 Remote Similarity NPD4703 Approved
0.6439 Remote Similarity NPD4702 Approved
0.6438 Remote Similarity NPD7947 Clinical (unspecified phase)
0.6438 Remote Similarity NPD4612 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data